PICINI: Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit

Sponsor
First Affiliated Hospital Xi'an Jiaotong University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03908866
Collaborator
(none)
200
1
2
9
22.2

Study Details

Study Description

Brief Summary

This study aim to compare the cost-effectiveness and safety between centrally and peripherally inserted central venous catheters in neurosurgical intensive care unit patients.

Condition or Disease Intervention/Treatment Phase
  • Other: PICC(Peripherally inserted central catheter)
  • Other: CVC(Central venous catheter )
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit. Comparative of Cost-Effectiveness and Safety
Actual Study Start Date :
Apr 1, 2019
Anticipated Primary Completion Date :
Dec 31, 2019
Anticipated Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: PICC(Peripherally inserted central catheter)

Patients randomly assigned to receive a peripherally inserted central catheter(PICC).

Other: PICC(Peripherally inserted central catheter)
The peripherally inserted central catheter with different sizes (French scale). Trained vascular access nurses will perform the insertion of the PICC, guided by ultrasound at bedside using the Seldinger technique. A suitable sterile field will be established.

Active Comparator: CVC(Central venous catheter )

Patients randomly assigned to receive a centrally inserted central venous catheter(CVC).

Other: CVC(Central venous catheter )
The central venous catheter with different sizes (French scale). Trained doctors will perform the insertion of the CVC, using the Seldinger technique. A suitable sterile field will be established.

Outcome Measures

Primary Outcome Measures

  1. thrombotic complications [up to 30 days or be discharged from hospital]

    radiographically-confirmed upper-extremity deep vein thrombosis

  2. mechanical complications [up to 30 days or be discharged from hospital]

    pneumothorax or hematoma caused by puncture

  3. infectious complications [up to 30 days or be discharged from hospital]

    catheter related bloodstream infection

Secondary Outcome Measures

  1. catheter replacement [up to 30 days or be discharged from hospital]

    obstruction or accidental removal

  2. cost effectiveness [up to 30 days or be discharged from hospital]

    The cost of catheter implantation and replacement, as well as the cost of treatment due to catheter-related complications and the resulting financial loss to the patient.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients admitted to the neurosurgical intensive care unit , who require central access for the treatment of their illness.
Exclusion Criteria:
  • Insertion of the central catheter in emergency situations;

  • Anatomical abnormalities of upper extremity affecting PICC placement;

  • Current or recent (within 1 month) diagnosis of bacteremia

  • Current or recent (within 1 year with confirmed resolution by imaging) deep venous thrombosis;

  • Presence of skin changes in the area of the puncture, such as thrombophlebitis, dermatitis, cellulitis, burn among others;

Contacts and Locations

Locations

Site City State Country Postal Code
1 First Affiliated Hospital of Xian Jiaotong University Xi'an Shaanxi China 710061

Sponsors and Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

Investigators

  • Principal Investigator: Hao Liu, MD, First Affiliated Hospital Xi'an Jiaotong University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
First Affiliated Hospital Xi'an Jiaotong University
ClinicalTrials.gov Identifier:
NCT03908866
Other Study ID Numbers:
  • XJTU1AF2019LSK-2019-032
First Posted:
Apr 9, 2019
Last Update Posted:
Apr 23, 2019
Last Verified:
Apr 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 23, 2019